Symptom-centric view

Product quality issue

Substances reporting Product quality issue disproportionately — ranked by ROR.

showing 4 of 4

Substance ↓	ROR [95% CI]	Reports	Category	Label
tretinoin Retin-A · Atralin	4.4 [3.9–5.0]	241	injectables	new
acetaminophen, aspirin, and caffeine —	2.6 [2.3–2.9]	345	algemeen	new
acetaminophen, aspirin (nsaid) and caffeine —	2.9 [2.6–3.3]	315	algemeen	new
abaloparatide —	5.9 [5.5–6.3]	915	algemeen	new

ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).